ADHD/SSRI - Documents, Articles & News Items

Doctors ordered to warn of antidepressant dangers

Lawmaker Says F.D.A. Held Back Drug Data

FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees

The ADHD Backlash

A Godsend, Till a Life Unravels

IT'S ABOUT TIME: L.I. MOM

FDA ISSUES PUBLIC HEALTH ADVISORY ON CAUTIONS
FOR USE OF ANTIDEPRESSANTS IN ADULTS AND CHILDREN

FDA debates anti-depressant risk to children

New York Times: Gardiner Harris, “Britain Says Use of Paxil by Children Is Dangerous”

"Children Shouldn't Use Glaxo Antidepressant -FDA" (6/19/2003)

BBC News: “Children ‘should not take Seroxat’” (6/10/03):

“Seroxat (Paxil) Has Serious Side Effects in Children: UK, Glaxo say Paxil increases suicidal behavior in children” (6/10/03):

The Guardian: Helen Walsh, “Touching the void: Regulators have just banned the prescription of the antidepressant Seroxat to under-18s. Novelist Helen Walsh, who was suicidal during her time on the drug, knows why.” (6/12/2003):

Website of the BBC-TV program, Panorama: The Secrets of Seroxat )aired October 13, 2002):

"GSK to change patient leaflet" (2003):

Sarah Boseley, “Mood drug Seroxat banned for under-18s” (6/11/2003):

Boseley, “Seroxat warning over risk to young: Suicidal feelings may be side effect for under-18s” (6/10/2003):

Vivienne Russell, “Seroxat ‘Not Suitable for Children’” (6/10/2003):

“Seroxat (Paxil) Has Serious Side Effects in Children: UK, Glaxo say Paxil increases suicidal behavior in children” (6/10/03):

Vera Hassner Sharav, ALLIANCE FOR HUMAN RESEARCH PROTECTION(AHRP), “US Senator Demands that FDA Puts Hold on GSK’s Request to Sell Paxil to Children, Orders Investigation” (6/13/03):

NY Post: Douglas Montero and Susan Edelman, “Mom Wants ‘Suicidal’ Drug Banned” (6/14/2003):

CNN: "FDA looking at Glaxo drug: Food and Drug Administration probes antidepressant Seroxat after Britain warns of suicide threat." (6/10/2003):

The City Pages: Beth Hawkins, “Paxil is Forever” (10/16/2002):

GlaxoSmithKline:

GSK's letter to Healthcare Professionals advising against use of Paxil in
treating children (6/18/2003):

Social Audit complaint dealing with the safety of paroxetine:

GSK responds to the Social Audit complaint:

FDA Paxil Product Label:

Seroxat User Group (UK):

Dr. David Healy’s Research:
“Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors” (2003):

“Emergence of Anti-depressant Induced Suicidality” (2000):

Other Scientific Research:
“Electric Shocks @ B The Serotonin Reuptake Inhibitor Withdrawal Syndrome” (1998):

FDA’s list of Paxil side effects:

“Paroxetine, Panorama and user reporting of ADRs: Consumer intelligence matters in clinical practice and post-marketing drug surveillance” (2002):

House Passes Bill To Ban Schools From Forced Medication

Child Medication Safety Act of 2003

Child Medication Safety Act of 2002

THE RITALIN OUTRAGE
FINALLY, A MEMBER OF CONGRESS TAKES A WHACK AT A DRUG PUSHER

By Nicholas Regush Redflagsweekly.com

RITALIN PUSHER CHANGES HIS TUNE ON SCHOOLS
By Douglas Montero New York Post

School Forced Boy onto Psycho RX Suit
By Douglas Montero New York Post

Could You Get Hooked On This Pill?
By Lisa Collier Cool

"I was told to dope my kid."
By Doug Montero (NY Post)

Mind Games
BBC

Antisuicidal Effect Of Psychotropics Remains Uncertain
Clinical Psychiatry News

Special Report: Prescription Drugs May Trigger Killing
Insight On The News

Judge: Paxil ads can't say it isn't habit-forming
USA Today

Surge in drugs given to kids draws concern
USA Today

The Next Generation Medical Guinea Pigs--Our Prozac, Zoloft and Paxil Babies
by Dr. Ann Blake Tracy, Director, International Coalition for Drug Awareness

Scientists Find Little, If Any, Proof Ritalin Is Effective
Canadian Medical Association Journal

Judge Bans Some Anti-Depressant Ads
By LOUINN LOTA Associated Press Writer

Wyoming jury awards $8 million to family of man involved in murder-suicide after taking Paxil
By Associated Press Writer

Could it be that antidepressants do little more than placebos
By Thomas J. Moore